Cipher appoints Dr. William Claypool to Board of Directors

05-Nov-2009 - Canada

Cipher Pharmaceuticals Inc. (announced that Dr. William Claypool, M.D., has been appointed to its Board of Directors.

Since October 2008, Dr. Claypool has been a Senior Partner at Pennmark Associates, LLC, a pharmaceutical development consulting firm. Prior to that, Dr. Claypool served as President, CEO and Chairman of Phoenix Data Systems, Inc, from January 2001 until it was acquired by Bio-Imaging Technologies, Inc. in March 2008. From January 2001 until June 2001, he served as President and CEO of The GI Company. From 1991 to 2001 Dr. Claypool held a number of senior management positions with SmithKline Beecham Pharmaceuticals, including Senior Vice-President and Director of Worldwide Clinical Development and Medical Affairs. Dr. Claypool has served as Director of ViroPharma since December 2003 and was a member of the Board of Directors and served on the Audit Committee of 3 Dimensional Pharmaceuticals. Dr. Claypool received his medical degree from the University of Connecticut School of Medicine.

Dr. Claypool will serve on Cipher's Nominating and Governance, Compensation, and Audit Committees.

Other news from the department people

More news from our other portals

So close that even
molecules turn red...